Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy
Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy have?
Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy has 40 citations in the OpenAlex counts ScholarIQ stores.
When was Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy published?
Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy has 2023 year in the ScholarIQ index.
What is the open-access status of Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy?
Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy has closed oa status in the ScholarIQ index.
What is the DOI of Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy?
The DOI for Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy is on the source record.
What is the PMID of Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy?
The PMID for Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy is on the source record.
What is the OpenAlex record for Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy?
The OpenAlex for Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy is on the source record.